Skip to main content
. 2016 Apr 15;7(23):34112–34130. doi: 10.18632/oncotarget.8746

Table 1. The details of primers used in this study.

Mouse Cyclin D1 Forward: 5′-GTG CCA TCC ATG GGG AA-3′Reverse: 5′-GGA TGG TCT GCT TGT TCT CA-3′
Mouse LARP7 Forward: 5′-TAT GGA AGA AAG CAC TAA GAG A-3′ Reverse: 5′-CAC ATA TAC CGT GCG TTC CTC C-3′
Mouse β-Actin Forward: 5′-ATA TCG CTG CGC TGG TCG TC-3′Reverse: 5′-AGG ATG GCG TGA GGG AGA GC-3′
Mouse GAPDH Forward: 5′-ATC AAG AAG GTG GTG AAG CAG GCA-3′Reverse: 5′-TCT CTT GCT CAG TGT CCT TGC TGG G-3′
Mouse Cyclin D1 3′UTR Forward: 5′-CCG CTC GAG AAA TGT ACT CTG CTT TGC TGA-3′Reverse: 5′-CTA GAC TAG TGA TCG CCA TCA GGG TCC CAG GA-3′
Mouse Cyclin D1 3′UTR miR-302d Point Mutation Primers Sense: 5′-AAA CCA TTC CAT TTC AAT CGT CTT TTG GTC AGC TAG CT-3′Antisense: 5′-AGC TAG CTG ACC AAA AGA CGA TTG AAA TGG AAT GGT TT-3′
Mouse LARP7 promoter Forward: 5′-CCG CTC GAG CAA TCA GTT TTT AGT CAG CAT-3′ Reverse: 5′-CCC AAG CTT GGG AGC CAC GCG GTG ACT GC-3′
Mouse LARP7 promoter CREB Point Mutation Primers Sense: 5′-CCA ACT TAA GTG ACG TCT ACA AGC AGG GAC GGT ACC-3′Antisense: 5′-GGT ACC GTC CCT GCT TGT AGA CGT CAC TTA AGT TGG-3′